bgb-a317
Showing 1 - 4 of 4
Colorectal Cancer, Adenoid Cystic Carcinoma Trial in Melbourne (TetMYB Vaccine, BGB-A317)
Active, not recruiting
- Colorectal Cancer
- Adenoid Cystic Carcinoma
- TetMYB Vaccine
- BGB-A317
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
May 16, 2022
Advanced Solid Tumors Trial in Australia, New Zealand, Spain (BGB-A333, BGB-A317)
Terminated
- Advanced Solid Tumors
- BGB-A333
- BGB-A317
-
Clayton, Victoria, Australia
- +7 more
Oct 12, 2021
Gastric Cancer Trial in Nanjing (BGB-A317, Anlotinib, Oxaliplatin)
Recruiting
- Gastric Cancer
- BGB-A317
- +3 more
-
Nanjing, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jul 5, 2021
Ovarian Cancer, Neoadjuvant Chemo, Anti-PD-1 Trial in Hangzhou (BGB-A317, albumin-bound paclitaxel 260mg/m2 , Carboplatin AUC 5)
Recruiting
- Ovarian Cancer
- +3 more
- BGB-A317
- albumin-bound paclitaxel 260mg/m2 , Carboplatin AUC 5
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital of Zhejiang University School of Medi
Mar 23, 2021